Rhythm Pharmaceuticals, Inc. RYTM Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s current debt?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported current debt of $10.13M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s current debt changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s current debt increased by 537.1% year-over-year, from $1.59M to $10.13M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.